triumph-3 retatrutide The numbers from Lilly's Phase 3 trial dropped this week and I haven't been able to stop thinking about them. Not only as a doctor but as a long-term GLP-1 user First Retatrutide phase 3 data,

13 An increase in the use of GLP1 RA as initial treatment in drugnaive patients has been observed in Denmark 14 regardless that no randomized clinical trial evidence has been published on how or whether GLP1 RA outperforms metformin in these patients

She is a licensed pharmacist in Wisconsin and is on the Board of Directors for the National Association of Specialty Pharmacy and the Drug Selection Advisory Committee for CivicaScript

Glucagon, which is added in retatrutide, is the next-generation drug

Ghezzawi, M

There was no change in prescribed doses of tacrolimus or graft rejection

July 2023: Phase 2 trial results indicated observed effects relevant to obesity, type 2 diabetes, and metabolic dysfunction-associated steatotic liver disease (MASLD)